mri: MRI data

Description Usage Format

Description

An MRI data set hosted on Scott Emerson's webpage. More detailed description is hosted there, at “http://www.emersonstatistics.com/datasets/mri.pdf”.

Usage

1

Format

A data frame with 735 observations on the following 30 variables.

ptid

participant identification number.

mridate

the date on which the participant underwent MRI scan in MMDDYY format.

age

participant age at time of MRI, in years.

male

indicator of whether participant is male (0=female, 1=male).

race

indicator of participant's race (1=white, 2=black, 3=Asian, 4=other).

weight

participant's weight at time of MRI (pounds).

height

participant's height at time of MRI (centimeters).

packyrs

participant smoking history in pack years (1 pack year = smoking 1 pack of cigarettes per day for 1 year). A participant who has never smoked has 0 pack years.

yrsquit

number of years since quitting smoking. A current smoker will have a nonzero packyrs and a 0 for yrsquit. A never smoker will have a zero for both variables.

alcoh

average alcohol intake for the participant for the two weeks prior to MRI (drinks per week, where one drink is 1 oz. whiskey, 4 oz. wine, or 12 oz.beer).

physact

physical activity of the participant for the week prior to MRI (1,000 kcal).

chf

indicator of whether the participant had been diagnosed with congestive heart failure prior to MRI (0=no, 1=yes).

chd

indicator of whether the participant had been diagnosed with coronary heart disease prior to MRI (0=no, 1=diagnosis of angina, 2=diagnosis of myocardial infarction).

stroke

indicator of whether the participant had been diagnosed with a cerebrovascular event prior to MRI (0=no, 1=diagnosis of a transient ischemic attack, 2=diagnosis of stroke).

diabetes

indicator of whether the participant had been diagnosed with diabetes prior to MRI (0=no, 1=yes).

genhlth

an indicator of the participant's view of their own health (1=excellent, 2=very good, 3=good, 4=fair, 5=poor)

ldl

a laboratory measure of low density lipoprotein (a kind of cholesterol) in the participant's blood at the time of MRI (mg/dL).

alb

a laboratory measure of albumin, a kind of protein, in the participant's blood at the time of MRI (g/L).

crt

a laboratory measure of creatinine, a waste product, in the participant's blood at the time of MRI (mg/dL).

plt

a laboratory measure of the number of platelets circulating in the participant's blood at the time of MRI (1000 per cubic mm).

sbp

a measurement of the participant's systolic blood pressure in their arm at the time of MRI (mm Hg).

aai

the ratio of systolic blood pressure measured in the participant's ankle at time of MRI to the systolic blood pressure in the participant's arm.

fev

a measure of the forced expiratory volume in the participant at the time of MRI (L/sec).

dsst

a measure of cognitive function (Digit Symbol Substitution Test) for the participant at the time of MRI. Maximum score possible is 100.

atrophy

a measure of global brain activity detected on MRI. Measurements range from 0 to 100, with 100 being the most severe atrophy.

whgrd

a measure of white matter changes detected on MRI. 0 means no changes, 9 means marked changes.

numinf

a count of the number of distinct regions identified on MRi scan which were suggestive of infarcts.

volinf

a measure of the total volume of infarct-like lesions found on MRI scan (cubic cm).

obstime

the total time (in days) that the participant was observed on study between the date of MRI and death or September 16, 1997, whichever came first.

death

an indicator that the participant was observed to die while on study. If 1, the number of days recorded in obstime is the number of days from that participant's MRI to their death. If 0, the number of days in obstime is the number of days between that participant's MRI and September 16, 1997.


uwIntroStats documentation built on May 2, 2019, 4:34 a.m.